Popiela Tadeusz, Kedra Boguslaw, Sierzega Marek, Gurda Anna
Ist Department of General and GI Surgery, Jagiellonian University, Krakow, Poland.
Hepatogastroenterology. 2004 Sep-Oct;51(59):1484-8.
BACKGROUND/AIMS: Pancreatic fistula remains one of the most common complications of pancreaticoduodenectomy. This study was carried out to identify relevant risk factors for the development of pancreatic fistula and to evaluate whether prophylactic administration of octreotide decreases their incidence.
Between March 1985 and December 2001, 129 consecutive patients who underwent elective pancreaticoduodenectomy for pancreatic or ampullary carcinomas were prospectively evaluated. Pancreatic fistula was defined as drainage of at least 10 mL of amylase-rich fluid detected in abdominal drains after the 3rd postoperative day.
The overall postoperative complication rate was 36.4% (n=47) and pancreatic fistula was found in 12.4% (n=16) of patients. No differences were found between patients receiving octreotide and the non-octreotide group regarding the incidence of postoperative complications, including pancreatic fistula. Univariate and multivariate analysis of factors predicting the development of pancreatic fistula showed that only soft pancreatic texture (p=0.0002) and ligation of the pancreatic remnant (p=0.029) were significantly associated with fistula formation.
The only surgeon-dependent factor which may reduce the incidence of stump-related complications is anastomosis of the pancreatic remnant with the alimentary tract. Carried out single-institution analysis showed octreotide to be ineffective in the prevention of pancreatic fistula following pancreaticoduodenectomy.
背景/目的:胰瘘仍然是胰十二指肠切除术最常见的并发症之一。本研究旨在确定胰瘘发生的相关危险因素,并评估预防性使用奥曲肽是否能降低其发生率。
在1985年3月至2001年12月期间,对129例因胰腺癌或壶腹癌接受择期胰十二指肠切除术的连续患者进行前瞻性评估。胰瘘定义为术后第3天腹部引流管中引流出至少10 mL富含淀粉酶的液体。
术后总体并发症发生率为36.4%(n = 47),12.4%(n = 16)的患者发生胰瘘。在接受奥曲肽治疗的患者和未接受奥曲肽治疗的患者之间,包括胰瘘在内的术后并发症发生率没有差异。对预测胰瘘发生的因素进行单因素和多因素分析显示,只有胰腺质地柔软(p = 0.0002)和胰腺残端结扎(p = 0.029)与瘘管形成显著相关。
唯一可能降低残端相关并发症发生率的外科医生相关因素是胰腺残端与消化道的吻合。单机构分析显示,奥曲肽在预防胰十二指肠切除术后胰瘘方面无效。